FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lithium carbonate filed by Rising Pharma Holdings, Inc. (ANDA205663).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)